— HUTCHMED will host in-person presentation and online webinar on Friday, October 31 — September 11, 2025 20:00 ET |…
CHONGQING, China, Sept. 3, 2025 /PRNewswire/ -- On August 29, SERES announced its 2025 mid-year results, reporting strong growth across all…
Pioneering solution provides scientists with actionable answers faster to accelerate scientific discovery COLUMBUS, Ohio, Aug. 4, 2025 /PRNewswire/ -- CAS,…
July 24, 2025 07:00 ET | Source: TCG Labs Soleil SAN FRANCISCO, July 24, 2025 (GLOBE NEWSWIRE) -- TCG Labs…
TOKYO, July 17, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY…
BOSTON, July 10, 2025 /PRNewswire/ -- Elevaris Medical Devices, a Contract Development and Manufacturing Organization (CDMO) for industry-leading, multi-national healthcare…
PFL-721 and PFL-241 are mutant-specific EGFR inhibitors with best-in-class potential, being developed as treatment options for emergent and unmet medical…